Search filters

List of works by Sandra Le Quellec

A single-centre study of management of pregnant women with von Willebrand disease

scientific article published on 18 December 2018

Clinical Evidence and Safety Profile of Emicizumab for the Management of Children with Hemophilia A

scientific article published on 03 February 2020

Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency

scientific article published on 4 April 2018

Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literature.

scientific article

Differential diagnosis of neonatal alloimmune thrombocytopenia: Type 2B von Willebrand disease.

scientific article

Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation.

scientific article

Emicizumab should be prescribed independent of immune tolerance induction

article

Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.

scientific article

In vivo efficacy of human recombinant factor IX produced by the human hepatoma cell line HuH-7.

scientific article published on 15 May 2015

Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots

scientific article published on 20 November 2020

Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins

scientific article published on 06 December 2018

Pre-analytical effects of pneumatic tube system transport on routine haematology and coagulation tests, global coagulation assays and platelet function assays

scientific article published on 28 December 2016

Septic arthritis caused by noncapsulated Haemophilus influenzae.

scientific article published on 20 March 2013

Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab.

scientific article published on 22 February 2018

Why patients with THBD c.1611C>A (p.Cys537X) nonsense mutation have high levels of soluble thrombomodulin?

scientific article published on 16 November 2017

Paulina is supported by:

About Paulina

Help